FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40585511000001107: Dasatinib anhydrous (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Apr 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1126401000001110 Dasatinib anhydrous en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1146871000001116 Dasatinib anhydrous (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dasatinib anhydrous Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dasatinib 39.5mg tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 79mg tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 63.2mg tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 110.6mg tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 15.8mg tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 79mg tablets 30 tablet Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 39.5mg tablets (Zentiva Pharma UK Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 79.0mg tablets (Zentiva Pharma UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 15.8mg tablets (Zentiva Pharma UK Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 15.8mg tablets 60 tablet Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 63.2mg tablets 30 tablet Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 110.6mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 63.2mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 79.0mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 39.5mg tablets 60 tablet Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 110.6mg tablets (Zentiva Pharma UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 15.8mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Dasatinib 110.6mg tablets 30 tablet Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 39.5mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier
Uxil 63.2mg tablets (Zentiva Pharma UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Dasatinib anhydrous Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start